Australian regulatory authorities have approved Safe Orthopaedics’ SteriSpine ranges, which are to be distributed in Australia and New Zealand, following a distribution agreement with SSJ Health.
Pierre Dumouchel, interim chief executive officer of Safe Orthopaedics, says, “This approval is a major step forward for us because it marks the introduction of our technologies in the Asia-Pacific region. It is the product of a partnership with SSJ Health, and we aim to achieve rapid uptake of our SteriSpine PS and SteriSpine LC ranges in Australia and New Zealand.”
The agreement will serve as a platform for starting up its business activities in the Australian and New Zealand markets, according to a press release. SSJ Health works directly with surgeons and hospitals in the region.
Craig Setter, chief executive officer of SSJ Health, adds, “Safe Orthopaedics’ sterile, single-use instruments and leading implants have the potential to…eliminate the risk of infection from the reuse of surgical instruments, cut hospital operating costs and facilitate increased reactivity to emergency surgeries.”
